| Luogo di origine: | La Cina |
|---|---|
| Marca: | HNB |
| Certificazione: | ISO |
| Numero di modello: | Fluconazolo |
| Quantità di ordine minimo: | 1kg |
| Prezzo: | Negotiable |
| Imballaggi particolari: | Borsa del di alluminio |
| Tempi di consegna: | Usually7-10days |
| Termini di pagamento: | L/C, D/A, D/P, T/T, , MoneyGram |
| Capacità di alimentazione: | 5000kg/Month |
| cas: | 86386-73-4 | MF: | C13H12F2N6O |
|---|---|---|---|
| Punto di fusione: | 306,27 | Specificazione: | ≥98% |
| Einecs no.: | 627-806-0 | Aspetto: | Polvere cristallina bianca |
CAS 86386-73-4 Antibacterial Raw Material Antifungals Fluconazole
| Prodcut name | Fluconazole |
| Synonyms | alpha-(2,4-Difluorophenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazole-1-ethanol; 2,4-Difluoro-alpha,alpha1-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol; |
| MOQ | 1G |
| CAS No. | 86386-73-4 |
| Appearance | white powder |
| Molecular Formula | C13H12F2N6O |
| Molecular Weight | 306.27 |
| Assay | 99% |
| Application | Pharma grade or research purpose |
The Introductction of Fluconazole :
Fluconazole powder is a triazole antifungal drug used in the treatment and prevention of superficial and systemic fungal infections. In a bulk powder form, it appears as a white crystalline powder, and it is very slightly soluble in water and soluble in alcohol.
The Application & Function of Fluconazole :
1. Fluconazole is indicated in the treatment of febrile neutropenia when fungal infections are suspected or proven.
2. Fluconazole is indicated in nonimmunocompromised patients for the treatment of onychomycosis caused by tinea unguium, Trichophyton species and Candida species.
3. Fluconazole is indicated for the treatment and suppression of cryptococcal meningitis.
4. Fluconazole is indicated in the treatment of pulmonary and disseminated coccidioidomycosis caused by Coccidioides immitis.
5. Fluconazole is indicated in the treatment of vulvovaginal candidiasis caused by Candida species.
6. Fluconazole is indicated for the treatment of serious infections, including peritonitis, pneumonia, and urinary tract infections, caused by susceptible Candida species.
7. Fluconazole is also indicated for the treatment of systemic infections caused by Candida species in neonates.
8. Fluconazole is indicated for the treatment of esophageal and oropharyngeal candidiasis (thrush) caused by Candida species.
9. Fluconazole is indicated for the prophylaxis of candidiasis in patients undergoing bone marrow transplant who receive cytotoxic chemotherapy and/or radiation therapy.
The COA of Fluconazole :
| Items | Standard | Results |
|
Appearance
|
Off-white or white crystal or crystalline powder | White crystalline powder |
| Melting point | 137-141ºC | 140ºC |
|
Identification
|
(1) (2) should comply with standard (3) should be positive reaction |
Complies Complies |
| Clarity of solution | Should comply with standard | Complies |
| Assay of fluorine | Should be between 11.1-12.4% | 12.3% |
| Involved substance | Should comply with standard | Complies |
| Assay of chloride | Should comply with standard | Complies |
| Loss on drying | Not more than 0.5% | 0.2% |
| Residue in ignition | Not more than 0.1% | 0.02% |
| Heavy metals | Not more than 20ppm | Complies |
| Limit of microbe | Should comply with standard | Complies |
| Assay | C13H12F2N6O should not less than 98.5% on dry basis | 10 |